Moreover, YBX1 enhances the expression of Interleukin-10 (IL-10), an anti-inflammatory cytokine that plays a key role in regulating immune responses and inhibiting excessive inflammation, and Transforming Growth Factor Beta (TGFβ), a cytokine involved in immune regulation, fibrosis, and tissue repair, by stabilizing their mRNAs, thereby impacting the progression of systemic lupus erythematosus (SLE) and type I diabetes, both of which are immune-mediated diseases [103,104]. Here, IL10 is linked to systemic lupus erythematosus.